Adverse Ruling. Any determination pursuant to this Section 11.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 6 contracts
Samples: License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Aduro Biotech, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 13.5 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 4 contracts
Samples: Collaboration and Option Agreement (Morphic Holding, Inc.), Collaboration and Option Agreement (Morphic Holding, Inc.), Collaboration and Option Agreement (Morphic Holding, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 17.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 3 contracts
Samples: Collaboration Agreement (Reata Pharmaceuticals Inc), Collaboration Agreement (Reata Pharmaceuticals Inc), Collaboration Agreement (Reata Pharmaceuticals Inc)
Adverse Ruling. Any determination pursuant to this Section 11.6 13.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 3 contracts
Samples: License Agreement (Reata Pharmaceuticals Inc), License Agreement (Reata Pharmaceuticals Inc), License Agreement (Reata Pharmaceuticals Inc)
Adverse Ruling. Any determination pursuant to this Section 11.6 14.7 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 3 contracts
Samples: Discovery Collaboration and License Agreement (Harpoon Therapeutics, Inc.), Discovery Collaboration and License Agreement (Harpoon Therapeutics, Inc.), Discovery Collaboration and License Agreement (CytomX Therapeutics, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 13.7 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 3 contracts
Samples: Development and Option Agreement (Harpoon Therapeutics, Inc.), Co Development and Option Agreement (Alector, Inc.), Co Development and Option Agreement (Alector, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 12.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 2 contracts
Samples: Development and License Agreement, Development and License Agreement (Principia Biopharma Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 17.2 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 2 contracts
Samples: Collaboration and Option Agreement (Voyager Therapeutics, Inc.), Collaboration and Option Agreement (Voyager Therapeutics, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 12.8 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Caribou Biosciences, Inc.), Collaboration and License Agreement (Caribou Biosciences, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 19 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (Idera Pharmaceuticals, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 11.7 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Adverse Ruling. Any determination pursuant to this Section 11.6 15.7 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: Discovery Collaboration and License Agreement (BICYCLE THERAPEUTICS PLC)
Adverse Ruling. Any determination pursuant to this Section 11.6 12.2 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: Collaboration and License Agreement (Ionis Pharmaceuticals Inc)
Adverse Ruling. Any determination pursuant to this Section 11.6 16.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Adverse Ruling. Any determination pursuant to this Section 11.6 made by the Neutral that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Immatics N.V.)
Adverse Ruling. Any determination pursuant to this Section 11.6 12.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: Exclusive Option Agreement (Aldeyra Therapeutics, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 12.5 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Adverse Ruling. Any determination pursuant to this Section 11.6 14.7 (Dispute Resolution) that a Party is in material breach of its material obligations hereunder shall will specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Adverse Ruling. Any determination pursuant to this Section 11.6 13.7 (Dispute Resolution) that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusive) set of actions to be taken to cure such material breach, if feasible.
Appears in 1 contract
Samples: Option and License Agreement (Alpine Immune Sciences, Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 14.5 that a Party is in material breach of its material obligations hereunder Material Breach shall specify a (nonexclusive) set of actions to be taken to cure such material breachMaterial Breach, if feasible.
Appears in 1 contract
Samples: Collaboration and License Agreement (REGENXBIO Inc.)
Adverse Ruling. Any determination pursuant to this Section 11.6 14.5.1 or Section 14.6 that a Party is in material breach of its material obligations hereunder shall specify a (nonexclusivenon-exclusive) set of actions to be taken to cure such material breach, if feasible..
Appears in 1 contract
